+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Allergic Conjunctivitis Market: By Disease Type, By Treatment Type & Geography - Forecast 2016-2021

  • ID: 3820834
  • Report
  • 165 pages
  • IndustryARC
1 of 3
Allergic conjunctivitis is defined as inflammation conjunctive in the eye caused due to an allergic reaction to substances like pollen, household dust, animal dander and mold spores especially during hay season. This disease is characterised by some of the common symptoms such as red, itchy, watery, and burning eyes are common symptoms of allergic conjunctivitis or puffy eyes in the morning. Globally increasing awareness amongst people about the disease and developing medical infrastructure in emerging economies providing easy access to the treatment for Allergic conjunctivitis treatments.

This report identifies the Allergic conjunctivitis market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to Allergic conjunctivitis treatment market.

North America is the largest market owing to the high prevalence of allergic conjunctivitis in the region. North American allergic conjunctivitis treatment market is followed by Europe and Asia-Pacific as second and third largest regional market respectively. Demand for the allergic conjunctivitis treatment is expected to grow fastest in the Asia Pacific region due to increasing medical infrastructure in the region making easy access for the treatments and also rapid urbanization and increasing pollution has resulted into higher cases for allergic conjunctivitis in the several regional countries.

This report segments global Allergic conjunctivitis treatment market on the basis of disease type, treatment type and regional market as follows:

This report on global allergic Conjunctivitis market also covers major disease type of allergice conjunctivitis including: Seasonal Allergic Conjunctivitis, Perennial Allergic Conjunctivitis, Giant Papillary Conjunctivitis, Vernal Kerato Conjunctivitis, Atopic Kerato Conjunctivitis
On the basis of current available treatments global allergic conjunctivitis market is segmented as follows: Antihistamines, Mast Cell Stabilizers, Olopatadine, Epinastine, Nonsteroidal Anti-Inflammatory Drugs and Others
This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets for allergic conjunctivitis in each of the region.

This report identifies all the major companies operating in the Allergic conjunctivitis treatment market. Some of the major companies’ profiles in detail are as follows:

Aciex Therapeutics
Sun Pharma Advanced Research Company Ocular Therapeutix
Sirion Therapeutics
Boehringer Ingelheim
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Global Allergic Conjunctivitis Market – Market Overview

2. Executive Summary

3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis

4. Global Allergic Conjunctivitis Market – Market Forces
4.1. Drivers
4.1.1. Developing medical infrastructure in emerging economies
4.1.2. Increasing awareness amongst people
4.2. Restraints
4.2.1. High cost for developing & testing the treatment
4.3. Opportunities
4.3.1. Developing an allergy specific treatment
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Global Allergic Conjunctivitis Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Global Allergic Conjunctivitis Market, By Disease Type (2014-2021)
6.1. Seasonal Allergic Conjunctivitis
6.2. Perennial Allergic Conjunctivitis
6.3. Giant Papillary Conjunctivitis
6.4. Vernal Kerato Conjunctivitis
6.5. Atopic Kerato Conjunctivitis

7. Global Allergic Conjunctivitis Market, By Treatment Type (2014-2021)
7.1. Antihistamines
7.2. Mast Cell Stabilizers
7.3. Olopatadine
7.4. Epinastine
7.5. Nonsteroidal Anti-Inflammatory Drugs
7.6. Others

8. Global Allergic Conjunctivitis Market, By Geography (2014-2021)
8.1. Europe
8.1.1. Germany
8.1.2. France
8.1.3. Italy
8.1.4. Spain
8.1.5. Russia
8.1.6. U.K.
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.3.1. U.S.
8.3.2. Canada
8.3.3. Mexico
8.4. Rest of the World (RoW)
8.4.1. Brazil
8.4.2. Rest of RoW

9. Allergic Conjunctivitis – Market Entropy
9.1. Expansion
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract

10. Company Profiles (Top 10 Companies)
10.1. Aciex Therapeutics
10.1.1. Introduction
10.1.2. Financials
10.1.3. Key Insights
10.1.4. Key Strategy
10.1.5. Product Portfolio
10.1.6. SWOT Analysis
10.2. Alcon/Novartis
10.2.1. Introduction
10.2.2. Financials
10.2.3. Key Insights
10.2.4. Key Strategy
10.2.5. Product Portfolio
10.2.6. SWOT Analysis
10.3. Allergan
10.3.1. Introduction
10.3.2. Financials
10.3.3. Key Insights
10.3.4. Key Strategy
10.3.5. Product Portfolio
10.3.6. SWOT Analysis
10.4. Sun Pharma Advanced Research Company Ocular Therapeutix
10.4.1. Introduction
10.4.2. Financials
10.4.3. Key Insights
10.4.4. Key Strategy
10.4.5. Product Portfolio
10.4.6. SWOT Analysis
10.5. Sirion Therapeutics
10.5.1. Introduction
10.5.2. Financials
10.5.3. Key Insights
10.5.4. Key Strategy
10.5.5. Product Portfolio
10.5.6. SWOT Analysis
10.6. Boehringer Ingelheim
10.6.1. Introduction
10.6.2. Financials
10.6.3. Key Insights
10.6.4. Key Strategy
10.6.5. Product Portfolio
10.6.6. SWOT Analysis
10.7. Atopix Therapeutics
10.7.1. Introduction
10.7.2. Financials
10.7.3. Key Insights
10.7.4. Key Strategy
10.7.5. Product Portfolio
10.7.6. SWOT Analysis
10.8. Laila Pharmaceuticals
10.8.1. Introduction
10.8.2. Financials
10.8.3. Key Insights
10.8.4. Key Strategy
10.8.5. Product Portfolio
10.8.6. SWOT Analysis
10.9. Laboratoires Thea S.A.
10.9.1. Introduction
10.9.2. Financials
10.9.3. Key Insights
10.9.4. Key Strategy
10.9.5. Product Portfolio
10.9.6. SWOT Analysis
10.10. Auven Therapeutics
10.10.1. Introduction
10.10.2. Financials
10.10.3. Key Insights
10.10.4. Key Strategy
10.10.5. Product Portfolio
10.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Expert Insights
Note: Product cover images may vary from those shown
3 of 3


4 of 3